posted on 2016-12-15, 09:36authored byM. Samuels, R. M. Ezzell, T. J. Cardozo, D. R. Critchley, J. L. Coll, E. D. Adamson
A mutant cell line, derived from the mouse embryonal carcinoma cell line F9, is defective in cell-cell adhesion (compaction) and in cell-substrate adhesion. We have previously shown that neither uvomorulin (E-cadherin) nor integrins are responsible for the mutant phenotype (Calogero, A., M. Samuels, T. Darland, S. A. Edwards, R. Kemler, and E. D. Adamson. 1991. Dev. Biol. 146:499-508). Several cytoskeleton proteins were assayed and only vinculin was found to be absent in mutant (5.51) cells. A chicken vinculin expression vector was transfected into the 5.51 cells together with a neomycin-resistance vector. Clones that were adherent to the substrate were selected in medium containing G418. Two clones, 5.51Vin3 and Vin4, were analyzed by Nomarski differential interference contrast and laser confocal microscopy as well as by biochemical and molecular biological techniques. Both clones adhered well to substrates and both exhibited F-actin stress fibers with vinculin localized at stress fiber tips in focal contacts. This was in marked contrast to 5.51 parental cells, which had no stress fibers and no vinculin. The mutant and complemented F9 cell lines will be useful models for examining the complex interactions between cytoskeletal and cell adhesion proteins.
Funding
This work was supported by United States Public Health Service grants
CA 54233 (E. D. Adamson) and IRG-173-C from the American Cancer
Association, funds from the Massachusetts General Hospital Center for the
Study of Inflammatory Bowel Disease (DK 43351) from the NIH (R. Ezzell)
and The Medical Research Council (UK) (D. R. Critchley). The Association
pour la Recherche sur le Cancer, Villejuif, France supported J-L.
Coll.
History
Citation
Journal of Cell Biology, 1993, 121 (4), pp. 909-921
Author affiliation
/Organisation/COLLEGE OF MEDICINE, BIOLOGICAL SCIENCES AND PSYCHOLOGY/MBSP Non-Medical Departments/Molecular & Cell Biology